Physician profile
Brian Burtch
NPI 1184745143
$264,007.22
in general payments reported to CMS, 2019-2025
33 companies · $298 in 2025
The $298 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120K · 2020: $38K · 2021: $60K · 2022: $33K · 2023: $7,233 · 2024: $5,789 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $919 · Travel and Lodging: $68.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,332.25 |
| Food and Beverage | $918.83 |
| Travel and Lodging | $68.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $113,372.62 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $79,659.70 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $36,855.40 | 2019-2024 | Jardiance, Mounjaro |
| Abbott Laboratories | $18,367.76 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,947.16 | 2019-2022 | |
| Novo Nordisk INC | $5,988.72 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Senseonics, Incorporated | $400.00 | 2019 | |
| Amgen INC. | $168.28 | 2019-2020 | |
| Amarin Pharma, INC. | $160.56 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $149.71 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $134.84 | 2019-2025 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $74.00 | 2019-2020 | |
| Corcept Therapeutics | $71.65 | 2019-2020 | |
| Medtronic, INC. | $69.03 | 2024-2025 | Minimed 780g |
| Radius Health, INC. | $62.82 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $59.94 | 2019 | |
| Pfizer INC. | $57.59 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.52 | 2019-2020 | |
| Sequel Med Tech, LLC | $38.59 | 2025 | Twiist |
| Janssen Pharmaceuticals, INC | $37.87 | 2019-2020 | |
| Lifescan, INC. | $36.48 | 2019-2020 | |
| Mannkind Corporation | $30.96 | 2019 | |
| Ibsa Pharma INC. | $30.02 | 2019-2020 | |
| Medtronic Minimed, INC. | $27.29 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.68 | 2019-2020 | |
| Abbvie INC. | $24.87 | 2019 | |
| Antares Pharma, INC. | $24.78 | 2019-2020 | |
| Gilead Sciences, INC. | $17.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.05 | 2019 | |
| Merck Sharp & Dohme LLC | $12.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.43 | 2019 | |
| Currax Pharmaceuticals LLC | $11.32 | 2019 | |
| Beta Bionics, INC. | $10.97 | 2023 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Burtch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.